Treatment of Complicated Staphylococcus aureus Bacteremia
JAMA Author Interviews
00:00
Evaluating Alternative Treatments for Staphylococcus Aureus Bacteremia
This chapter explores a clinical trial assessing the effectiveness and safety of dablovancin versus standard therapy for staphylococcus aureus bacteremia. It highlights trial outcomes, including secondary endpoints of clinical efficacy and safety, while noting the unexpected similarity in quality of life reports between patients receiving both treatments.
Transcript
Play full episode
